Faeth Therapeutics (FTH) Total Assets by Year
Faeth Therapeutics, Inc. closed fiscal year 2025 with $22.9M in total assets, $4.3M in total liabilities and $18.6M in shareholder equity. Total assets fell 49.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Faeth Therapeutics, Inc. has filed alongside them.
Ticker history: SNSE became FTH (Faeth Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View SNSE history.
Annual figures, oldest first. Point at a bar to read its period.
FTH Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing |
|---|---|---|---|---|---|---|
| Total Assets | $22.9M-49.5% | $45.4M-39.0% | $74.4M-37.2% | $118.4M-22.7% | $153.2M+615.1% | $21.4M |
| Total Liabilities | $4.3M-38.2% | $7.0M-26.4% | $9.5M-36.7% | $15.0M+123.0% | $6.7M-91.4% | $77.9M |
| Total Equity | $18.6M-51.6% | $38.4M-40.8% | $64.9M-37.2% | $103.4M-29.4% | $146.5Mn/m | -$56.4M |
FTH Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25Filing | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $178.9M+548.6% | $189.3M+495.6% | $205.4M+436.6% | $22.9M-49.5% | $27.6M-48.2% | $31.8M-46.9% | $38.3M-42.6% | $45.4M-39.0% | $53.3M-34.8% | $59.8M-33.2% | $66.7M-38.2% | $74.4M-37.2% |
| Total Liabilities | $11.1M+141.9% | $9.6M+114.4% | $342.7M+5351.3% | $4.3M-38.2% | $4.6M-38.7% | $4.5M-41.3% | $6.3M-23.5% | $7.0M-26.4% | $7.5M-29.9% | $7.6M-26.7% | $8.2M-37.2% | $9.5M-36.7% |
| Total Equity | $161.1M+600.2% | $173.0M+533.2% | -$137.3M-529.2% | $18.6M-51.6% | $23.0M-49.7% | $27.3M-47.7% | $32.0M-45.3% | $38.4M-40.8% | $45.8M-35.5% | $52.2M-34.1% | $58.5M-38.4% | $64.9M-37.2% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Faeth Therapeutics, Inc. financials
Frequently Asked Questions
Faeth Therapeutics, Inc. closed fiscal year 2025 with $22.9M in total assets, $4.3M in total liabilities and $18.6M in shareholder equity.
Faeth Therapeutics, Inc. (FTH) total assets fell by 49.5% year over year, from $45.4M to $22.9M in fiscal year 2025.
Across the 6 fiscal years this page covers, Faeth Therapeutics, Inc. (FTH) total assets went from $21.4M in fiscal year 2020 to $22.9M in fiscal year 2025.
Faeth Therapeutics, Inc. (FTH) reported $178.9M in total assets in Q3 2026. This represents an increase of 548.6% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Faeth Therapeutics, Inc. (FTH) reported on that line in every period on record.